Marcie A. Goldstein
Lawyers
Represents broker-dealers and issuers on securities law compliance and FINRA requirements.
Marcie represents broker-dealers and issuers in connection with public and private securities offerings, mergers and other corporate transactions with respect to compliance with state securities laws and FINRA requirements.
Experience
Recent Work
- Bold Eagle Acquisition $250 million IPO
- MBX Biosciences $188 million IPO
- EverBank $150 million subordinated notes offering
- Life Time $300 million follow-on offering
- Alkami Technology $155.9 million secondary offering
- CytomX Therapeutics $58.3 million at-the-market offering
- TWFG $187 million IPO
- CCC Intelligent Solutions Holdings $339 million secondary offering
- WEBTOON Entertainment $315 million IPO
- Tempus AI $410 million IPO
- Kenvue $3.7 billion debt for equity exchange and secondary offering
- RxSight $115 million follow-on offering
- Oculis Holding $100 million at-the-market offering
- Intra-Cellular Therapies $500 million stock offering
- Haleon $3.1 billion secondary offering
- Reddit $748 million IPO
Education
J.D., Wayne State University Law School
B.A., University of Michigan
- with honors
Prior experience
- Examiner, Michigan Corporation & Securities Bureau, 1980-1981
- Assistant Director, Corporate Financing, National Association of Securities Dealers, 1982-1983
Qualifications and admissions
- State of New York